短程间歇全监化疗方案治疗涂阳肺结核已取得了满意的近期疗效和２年的远期疗效。为了进一步评价方案的效果，对治愈的６４９例涂片阳性肺结核病人进行了５年随访研究。５年中丢失２例，死亡６１例，外迁３例，实际完成随访５８３例，复发４９例，总复发率为８．４％，其中新发病人为６．４％，夏治病人为１０．１％。 Short-term intermittent total regimen of chemotherapy treatment of smear positive pulmonary tuberculosis has made satisfactory short-term efficacy and long-term efficacy of 2 years. In order to further evaluate the efficacy of the program, a follow-up study was conducted on 649 cured smear-positive pulmonary tuberculosis patients for 5 years. In 5 years, 2 cases were lost, 61 died and 3 cases were relocated. In fact, 583 cases were followed up and 49 cases were relapsed, with a total recurrence rate of 8.4%. Among them, 6.4% were newly diagnosed and 10 were treated in summer. 1%.